title: Continuous subcutaneous insulin pump treatment associated with absence of recurrent kidney allograft diabetic nephropathy.
authors.affiliation: University Hospital of Lausanne, University of Lausanne, Lausanne, Switzerland. Matthieu.Halfon@chuv.ch.
authors.forename: Matthieu
authors.initials: M
authors.lastname: Halfon
authors.affiliation: University Hospital of Lausanne, University of Lausanne, Lausanne, Switzerland.
authors.forename: Samuel
authors.initials: S
authors.lastname: Rotman
authors.affiliation: University Hospital of Lausanne, University of Lausanne, Lausanne, Switzerland.
authors.forename: Marc
authors.initials: M
authors.lastname: Egli
authors.affiliation: University Hospital of Lausanne, University of Lausanne, Lausanne, Switzerland.
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Venetz
authors.affiliation: University Hospital of Lausanne, University of Lausanne, Lausanne, Switzerland. Manuel.Pascual@chuv.ch.
authors.forename: Manuel
authors.initials: M
authors.lastname: Pascual
mesh_terms: D000328:Adult; D064591:Allografts; D003404:Creatinine / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003928:Diabetic Nephropathies / Q000517:prevention & control*; D015809:HLA-DR7 Antigen / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use*; D007332:Insulin Infusion Systems; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male
chemical_list: D015809:HLA-DR7 Antigen; D007004:Hypoglycemic Agents; D007328:Insulin; D003404:Creatinine